Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Information (Unaudited)

v3.21.1
Quarterly Financial Information (Unaudited)
6 Months Ended
Dec. 31, 2020
Quarterly Financial Information (Unaudited)  
Quarterly Financial Information (Unaudited)

Note 10—Quarterly Financial Information (Unaudited)

 

The following tables contain unaudited consolidated quarterly financial information for the quarterly period ended September 30, 2020 that has been updated to reflect the restatement and revision of the Company’s consolidated financial statements as described in Note 2—Restatement of Previously Issued Financial Statements. The restatement and revision had no impact on net cash flows from operating, investing or financing activities. The Company has not amended its previously filed Quarterly Report on Form 10-Q for the Affected Period. The financial information that has been previously filed or otherwise reported for the Affected Period is superseded by the information in this Annual Report, and the financial statements and related financial information for the Affected Period contained in such previously filed report should no longer be relied upon.

 

 

 

 

 

 

 

 

 

 

 

 

 

As of  September 30, 2020

 

 

As Previously 

 

Restatement 

 

 

 

 

    

Reported

    

Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

Balance Sheet

 

 

 

 

 

 

 

 

 

Total assets

 

$

216,445,723

 

$

 —

 

$

216,445,723

Liabilities and shareholders’ equity

 

 

  

 

 

  

 

 

  

Total current liabilities

 

$

161,956

 

$

 —

 

$

161,956

Deferred legal fees

 

 

 —

 

 

  

 

 

  

Deferred underwriting commissions

 

 

7,525,000

 

 

 —

 

 

7,525,000

Derivative warrant liabilities

 

 

 —

 

 

16,197,500

 

 

16,197,500

Total liabilities

 

 

7,686,956

 

 

16,197,500

 

 

23,884,456

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

 

203,758,760

 

 

(16,197,500)

 

 

187,561,260

Shareholders’ equity

 

 

  

 

 

  

 

 

  

Preference shares - $0.0001 par value

 

 

 —

 

 

 —

 

 

 —

Class A ordinary shares - $0.0001 par value

 

 

112

 

 

162

 

 

274

Class B ordinary shares - $0.0001 par value

 

 

538

 

 

 —

 

 

538

Additional paid-in-capital

 

 

5,190,381

 

 

601,798

 

 

5,792,179

Accumulated deficit

 

 

(191,024)

 

 

(601,960)

 

 

(792,984)

Total shareholders’ equity

 

 

5,000,007

 

 

 —

 

 

5,000,007

Total liabilities and shareholders’ equity

 

$

216,445,723

 

$

 —

 

$

216,445,723

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period From June 24, 2020 (Inception) Through September 30, 2020

 

 

As Previously 

 

Restatement 

 

 

 

 

    

Reported

    

Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Statement of Operations

 

 

 

 

 

 

 

 

 

Loss from operations

 

$

(201,002)

 

$

 —

 

$

(201,002)

Other (expense) income:

 

 

  

 

 

  

 

 

  

Change in fair value of warrant liabilities

 

 

 —

 

 

 —

 

 

 —

Offering costs associated with derivative warrant liabilities

 

 

 —

 

 

(601,960)

 

 

(601,960)

Net gain from investments held in Trust Account

 

 

9,978

 

 

 —

 

 

9,978

Total other (expense) income

 

 

9,978

 

 

(601,960)

 

 

(591,982)

Net loss

 

$

(191,024)

 

$

(601,960)

 

$

(792,984)

 

 

 

 

 

 

 

 

 

 

Basic and Diluted weighted-average Class A ordinary shares outstanding

 

 

21,500,000

 

 

 —

 

 

21,500,000

Basic and Diluted net loss per Class A share

 

$

0.00

 

 

 —

 

$

0.00

Basic and Diluted weighted-average Class B ordinary shares outstanding

 

 

5,162,280

 

 

 —

 

 

5,162,280

Basic and Diluted net loss per Class B share

 

$

(0.04)

 

 

 —

 

$

(0.16)

 

 

 

 

 

 

 

 

 

 

 

 

 

Period From June 24, 2020 (Inception) Through September 30, 2020

 

 

As Previously 

 

Restatement 

 

 

 

 

    

Reported

    

Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Statement of Cash Flows

 

 

 

 

 

 

 

 

 

Net loss

 

$

(191,024)

 

$

(601,960)

 

$

(792,984)

  Offering costs associated with derivative warrant liabilities    

 

 

 —

 

 

601,960

 

 

601,960

Net cash used in operating activities

 

 

(393,915)

 

 

 —

 

 

(393,915)

Net cash used in investing activities

 

 

(215,000,000)

 

 

 —

 

 

(215,000,000)

Net cash provided by financing activities

 

 

216,459,791

 

 

 —

 

 

216,459,791

Net change in cash

 

$

1,065,876

 

$

 —

 

$

1,065,876